Paul Proost
Laboratory of Molecular Immunology
Rega Institute
K.U.Leuven
Leuven
Belgium
Name/email consistency: high
- Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation. Proost, P., Loos, T., Mortier, A., Schutyser, E., Gouwy, M., Noppen, S., Dillen, C., Ronsse, I., Conings, R., Struyf, S., Opdenakker, G., Maudgal, P.C., Van Damme, J. J. Exp. Med. (2008)
- Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration. Proost, P., Mortier, A., Loos, T., Vandercappellen, J., Gouwy, M., Ronsse, I., Schutyser, E., Put, W., Parmentier, M., Struyf, S., Van Damme, J. Blood (2007)
- Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies. Proost, P., Struyf, S., Loos, T., Gouwy, M., Schutyser, E., Conings, R., Ronsse, I., Parmentier, M., Grillet, B., Opdenakker, G., Balzarini, J., Van Damme, J. Arthritis Res. Ther. (2006)
- Natural post-translational modifications of chemokines. Proost, P., Struyf, S., Van Damme, J. Biochem. Soc. Trans. (2006)
